search
Back to results

Cycling of Sedative Infusions in Critically Ill Pediatric Patients

Primary Purpose

Respiratory Failure

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Midazolam
Normal saline
Fentanyl
Sponsored by
Javier Gelvez, MD
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Failure focused on measuring Sedation, Cycling, Pediatric

Eligibility Criteria

undefined - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Less than or equal to 18 years of age
  • Intubated and mechanically ventilated
  • Expected to require continuous infusions of sedatives for at least 48 hours
  • Parent or legal guardian available for informed consent
  • Males and females of any race are eligible

Exclusion Criteria:

  • Less than 72 hours after surgery
  • Cyanotic heart disease with unrepaired or palliated right to left intracardiac shunt
  • Critical airway (according to PICU Attending)
  • Ventilator dependent (including noninvasive) on PICU admission
  • Greater than 48 hours of continuous sedation infusion(s)
  • Neuromuscular respiratory failure
  • Managed by patient controlled analgesia (PCA) or epidural catheter
  • Known allergy to any of the study medications (fentanyl or midazolam)
  • Family/Medical team have decided not to provide full support (patient treatment considered futile)
  • Patient requires ECMO
  • Head trauma requiring intracranial pressure monitoring
  • Pregnancy
  • Following resuscitation from cardiorespiratory arrest whose initial pH is < 6.9
  • ICU Attending judgment that patient should be excluded for safety reasons

Sites / Locations

  • Cook Children's Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Experimental Group

Control Group

Arm Description

In this arm Fentanyl and Midazolam was replaced with placebo (normal saline) during cycling. At cycling time for midazolam, the continuous infusion of midazolam was stopped by the bedside nurse. The nurse started a pump containing a syringe labeled "Study Drug M" which contained the placebo drug (normal saline). The switch to Study Drug M occurred twice daily at 0800 and 2000 for a period of 3 hours each. At cycling time for fentanyl, the continuous infusion of fentanyl was stopped by the bedside nurse. The pump containing a syringe labeled "Study Drug F," which contained the placebo drug (normal saline), was started. The switch Study Drug F occurred twice daily at 1400 and 0200 for a period of 3 hours each. Dosing was done per standard of care and not prescribed per protocol

In this arm, midazolam and fentanyl were administered during cycling. At cycling time for midazolam, the continuous infusion of midazolam was stopped by the bedside nurse. The nurse started a pump containing a syringe labeled "Study Drug M" which contained the control drug (midazolam). The switch to Study Drug M occurred twice daily at 0800 and 2000 for a period of 3 hours each. At cycling time for fentanyl, the continuous infusion of fentanyl was stopped by the bedside nurse. The pump containing a syringe labeled "Study Drug F," which contained the control drug (fentanyl), was started. The switch to Study Drug F occurred twice daily at 1400 and 0200 for a period of 3 hours each. Dosing was done per standard of care and not prescribed per protocol.

Outcomes

Primary Outcome Measures

Duration of Mechanical Ventilation Days
Participants will be followed for an expected average of 4 days. The Data Safety Monitoring Group will review the data every 6 months.

Secondary Outcome Measures

PICU Length of Stay
Participants will be followed for an expected average of 7 days. This secondary endpoint is to be evaluated every six months.
Hospital Length of Stay
Participants will be followed for an expected average of 7 days in PICU and 10 days of hospitalization. This secondary endpoint is to be evaluated every six months.

Full Information

First Posted
April 6, 2011
Last Updated
January 2, 2019
Sponsor
Javier Gelvez, MD
search

1. Study Identification

Unique Protocol Identification Number
NCT01333059
Brief Title
Cycling of Sedative Infusions in Critically Ill Pediatric Patients
Official Title
A Randomized, Double-blind, Controlled Trial of Cycling Continuous Sedative Infusions in Critically Ill Pediatric Patients Requiring Mechanical Ventilation
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Terminated
Why Stopped
Unable to adequately enroll over a reasonable enrollment period.
Study Start Date
September 2010 (undefined)
Primary Completion Date
October 2012 (Actual)
Study Completion Date
January 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Javier Gelvez, MD

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine if the reduction of the total amount of sedative critically pediatric ill patients receive in the PICU will achieve a significant decrease in mechanical ventilation days and a decrease in the overall length of stay in the PICU and hospital.
Detailed Description
Continuous sedative infusions have been associated with longer duration of mechanical ventilation, longer stay in the intensive care unit (PICU) and total hospital stay. Also, extended duration of continuous sedative infusions limits the ability to assess for adequate neurologic function. There is, however, no published data on the use of daily interruption of continuous sedative infusions in pediatric patients, nor are there any recommendations from the leading pediatric critical care groups regarding this issue. Infants and children exposed to noxious stimuli (endotracheal tube, endotracheal suctioning, mechanical ventilation, indwelling catheters) in addition to an unknown environment are less likely to cooperate during normal daily interventions in the PICU. Continuous infusions of benzodiazepines and opioids in addition to as needed (PRN) bolus doses have been the standard of care in our institution for mechanically ventilated patients. The study seeks to determine if reducing the total dose of sedatives, by holding them in a cyclical manner, will be a safe and effective intervention that will not increase adverse patient outcomes. This will be achieved by limiting the patient tolerance to the sedatives, decreasing the body total deposit of sedatives and subsequently decreases awakening time when patient is ready for extubation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Failure
Keywords
Sedation, Cycling, Pediatric

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental Group
Arm Type
Experimental
Arm Description
In this arm Fentanyl and Midazolam was replaced with placebo (normal saline) during cycling. At cycling time for midazolam, the continuous infusion of midazolam was stopped by the bedside nurse. The nurse started a pump containing a syringe labeled "Study Drug M" which contained the placebo drug (normal saline). The switch to Study Drug M occurred twice daily at 0800 and 2000 for a period of 3 hours each. At cycling time for fentanyl, the continuous infusion of fentanyl was stopped by the bedside nurse. The pump containing a syringe labeled "Study Drug F," which contained the placebo drug (normal saline), was started. The switch Study Drug F occurred twice daily at 1400 and 0200 for a period of 3 hours each. Dosing was done per standard of care and not prescribed per protocol
Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
In this arm, midazolam and fentanyl were administered during cycling. At cycling time for midazolam, the continuous infusion of midazolam was stopped by the bedside nurse. The nurse started a pump containing a syringe labeled "Study Drug M" which contained the control drug (midazolam). The switch to Study Drug M occurred twice daily at 0800 and 2000 for a period of 3 hours each. At cycling time for fentanyl, the continuous infusion of fentanyl was stopped by the bedside nurse. The pump containing a syringe labeled "Study Drug F," which contained the control drug (fentanyl), was started. The switch to Study Drug F occurred twice daily at 1400 and 0200 for a period of 3 hours each. Dosing was done per standard of care and not prescribed per protocol.
Intervention Type
Drug
Intervention Name(s)
Midazolam
Other Intervention Name(s)
Versed, Study Drug M
Intervention Type
Drug
Intervention Name(s)
Normal saline
Other Intervention Name(s)
Placebo
Intervention Type
Drug
Intervention Name(s)
Fentanyl
Other Intervention Name(s)
Subsys, Duragesic, Abstral, Lazanda, IONSYS, Study Drug F
Primary Outcome Measure Information:
Title
Duration of Mechanical Ventilation Days
Description
Participants will be followed for an expected average of 4 days. The Data Safety Monitoring Group will review the data every 6 months.
Time Frame
From date of randomization until the date of discharge from PICU, assessed up to 1 month
Secondary Outcome Measure Information:
Title
PICU Length of Stay
Description
Participants will be followed for an expected average of 7 days. This secondary endpoint is to be evaluated every six months.
Time Frame
From date of randomization until the date of discharge from PICU, assessed up to 1 month
Title
Hospital Length of Stay
Description
Participants will be followed for an expected average of 7 days in PICU and 10 days of hospitalization. This secondary endpoint is to be evaluated every six months.
Time Frame
From date of hospital admission to date of hospital discharge, assessed up to 6 weeks

10. Eligibility

Sex
All
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Less than or equal to 18 years of age Intubated and mechanically ventilated Expected to require continuous infusions of sedatives for at least 48 hours Parent or legal guardian available for informed consent Males and females of any race are eligible Exclusion Criteria: Less than 72 hours after surgery Cyanotic heart disease with unrepaired or palliated right to left intracardiac shunt Critical airway (according to PICU Attending) Ventilator dependent (including noninvasive) on PICU admission Greater than 48 hours of continuous sedation infusion(s) Neuromuscular respiratory failure Managed by patient controlled analgesia (PCA) or epidural catheter Known allergy to any of the study medications (fentanyl or midazolam) Family/Medical team have decided not to provide full support (patient treatment considered futile) Patient requires ECMO Head trauma requiring intracranial pressure monitoring Pregnancy Following resuscitation from cardiorespiratory arrest whose initial pH is < 6.9 ICU Attending judgment that patient should be excluded for safety reasons
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Javier Gelvez, MD
Organizational Affiliation
Cook Children's Physician Network
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Linda L Thompson, MD
Organizational Affiliation
Cook Children's Physician Network
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cook Children's Medical Center
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76104
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
10816184
Citation
Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000 May 18;342(20):1471-7. doi: 10.1056/NEJM200005183422002.
Results Reference
background
PubMed Identifier
9726743
Citation
Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998 Aug;114(2):541-8. doi: 10.1378/chest.114.2.541.
Results Reference
background
PubMed Identifier
11902253
Citation
Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA Jr, Murray MJ, Peruzzi WT, Lumb PD; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002 Jan;30(1):119-41. doi: 10.1097/00003246-200201000-00020. No abstract available. Erratum In: Crit Care Med 2002 Mar;30(3):726.
Results Reference
background
PubMed Identifier
15636661
Citation
Ista E, van Dijk M, Tibboel D, de Hoog M. Assessment of sedation levels in pediatric intensive care patients can be improved by using the COMFORT "behavior" scale. Pediatr Crit Care Med. 2005 Jan;6(1):58-63. doi: 10.1097/01.PCC.0000149318.40279.1A.
Results Reference
background
PubMed Identifier
15659992
Citation
van Dijk M, Peters JW, van Deventer P, Tibboel D. The COMFORT Behavior Scale: a tool for assessing pain and sedation in infants. Am J Nurs. 2005 Jan;105(1):33-6. doi: 10.1097/00000446-200501000-00019. No abstract available.
Results Reference
background
PubMed Identifier
14525802
Citation
Kress JP, Gehlbach B, Lacy M, Pliskin N, Pohlman AS, Hall JB. The long-term psychological effects of daily sedative interruption on critically ill patients. Am J Respir Crit Care Med. 2003 Dec 15;168(12):1457-61. doi: 10.1164/rccm.200303-455OC. Epub 2003 Oct 2.
Results Reference
background
PubMed Identifier
17205005
Citation
Kress JP, Vinayak AG, Levitt J, Schweickert WD, Gehlbach BK, Zimmerman F, Pohlman AS, Hall JB. Daily sedative interruption in mechanically ventilated patients at risk for coronary artery disease. Crit Care Med. 2007 Feb;35(2):365-71. doi: 10.1097/01.CCM.0000254334.46406.B3.
Results Reference
background
PubMed Identifier
18244955
Citation
Colville G, Kerry S, Pierce C. Children's factual and delusional memories of intensive care. Am J Respir Crit Care Med. 2008 May 1;177(9):976-82. doi: 10.1164/rccm.200706-857OC. Epub 2008 Jan 31.
Results Reference
background
PubMed Identifier
15069396
Citation
Connolly D, McClowry S, Hayman L, Mahony L, Artman M. Posttraumatic stress disorder in children after cardiac surgery. J Pediatr. 2004 Apr;144(4):480-4. doi: 10.1016/j.jpeds.2003.12.048.
Results Reference
background
Links:
URL
http://www.cookchildrens.org
Description
Click here for more information about this study: A randomized, double-blind, controlled trial of cycling continuous sedative infusions in critically ill pediatric patients requiring mechanical ventilation

Learn more about this trial

Cycling of Sedative Infusions in Critically Ill Pediatric Patients

We'll reach out to this number within 24 hrs